Loading clinical trials...
Loading clinical trials...
The REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) Post Approval Study
Conditions
Locations
123
United States
Birmingham, Alabama, United States
Anchorage, Alaska, United States
Chandler, Arizona, United States
Gilbert, Arizona, United States
Jonesboro, Arkansas, United States
Little Rock, Arkansas, United States
Start Date
April 1, 2012
Primary Completion Date
April 1, 2022
Completion Date
April 1, 2022
Last Updated
April 18, 2022
NCT07083011
NCT07037459
NCT07550790
NCT06148935
NCT06874556
NCT06741436
Lead Sponsor
Medtronic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions